Intracranial Activity of Selpercatinib in Chinese Patients With Advanced RET Fusion-Positive Non-Small-Cell Lung Cancer in the Phase II LIBRETTO-321 Trial.
Ying ChengDingzhi HuangJianying ZhouChengzhi ZhouYuping SunLin WuYe GuoShao JingxinWanli ZhangShun LuPublished in: JCO precision oncology (2023)
-altered NSCLC, consistent with the global LIBRETTO-001 trial.